Potential biomarkers associated with malignancy in uterine mesenchymal tumors

Takuma Hayashi; Nobuo Yaegashi; Susumu Tonegawa; Ikuo Konishi

doi:10.31083/j.ejgo4205125

Potential biomarkers associated with malignancy in uterine mesenchymal tumors

Takuma Hayashi, Nobuo Yaegashi, Susumu Tonegawa, Ikuo Konishi

MED - Medical Sciences

Research output: Contribution to journal › Review article › peer-review

1 Citation (Scopus)

Original language	English
Pages (from-to)	824-828
Number of pages	5
Journal	European Journal of Gynaecological Oncology
Volume	42
Issue number	5
DOIs	https://doi.org/10.31083/j.ejgo4205125
Publication status	Published - 2021 Oct 15

ASJC Scopus subject areas

Oncology
Obstetrics and Gynaecology

Access to Document

10.31083/j.ejgo4205125

Cite this

@article{a70967e35bc0494a958a88a6e746c6f7,

title = "Potential biomarkers associated with malignancy in uterine mesenchymal tumors",

author = "Takuma Hayashi and Nobuo Yaegashi and Susumu Tonegawa and Ikuo Konishi",

note = "Funding Information: This clinical research was performed with the support of the following research funding: Japan Society for the Promotion of Science for TH (grant No. 19K09840), START-program Japan Science and Technology Agency (JST) for TH (grant No. STSC20001), and National Hospital Organization Multicenter clinical study for TH (grant No. 2019-Cancer in general-02). This work was supported by grants from the Ministry of Education, Culture, Science and Technology (No. 15K10709), START-project of Japan Science and Technology Agency, the Foundation for the Promotion of Cancer Research, Kanzawa Medical Research Foundation, and The Ichiro Kanehara Foundation. Funding Information: We sincerely appreciate the generous donation of PSMB9/β1i-deficient breeding mice and technical comments by Luc Van Kaer, at Massachusetts Institute of Technology. We thank Isamu Ishiwata for his generous gift of the human Ut-LMS cell lines. We appreciate the technical assistance of the research staff at Harvard Medical School. We are grateful to clinical staffs at Hyogo Cancer Center for Adults for clinical materials and helpful discussion. This clinical research was performed with the support of the following research funding: Japan Society for the Promotion of Science for TH (grant No. 19K09840), START-program Japan Science and Technology Agency (JST) for TH (grant No. STSC20001), and National Hospital Organization Multicenter clinical study for TH (grant No. 2019-Cancer in general-02). This work was supported by grants from the Ministry of Education, Culture, Science and Technology (No. 15K10709), START-project of Japan Science and Technology Agency, the Foundation for the Promotion of Cancer Research, Kanzawa Medical Research Foundation, and The Ichiro Kanehara Foundation.",

year = "2021",

month = oct,

day = "15",

doi = "10.31083/j.ejgo4205125",

language = "English",

volume = "42",

pages = "824--828",

journal = "European Journal of Gynaecological Oncology",

issn = "0392-2936",

publisher = "S.O.G. CANADA Inc.",

number = "5",

}

TY - JOUR

T1 - Potential biomarkers associated with malignancy in uterine mesenchymal tumors

AU - Hayashi, Takuma

AU - Yaegashi, Nobuo

AU - Tonegawa, Susumu

AU - Konishi, Ikuo

N1 - Funding Information: This clinical research was performed with the support of the following research funding: Japan Society for the Promotion of Science for TH (grant No. 19K09840), START-program Japan Science and Technology Agency (JST) for TH (grant No. STSC20001), and National Hospital Organization Multicenter clinical study for TH (grant No. 2019-Cancer in general-02). This work was supported by grants from the Ministry of Education, Culture, Science and Technology (No. 15K10709), START-project of Japan Science and Technology Agency, the Foundation for the Promotion of Cancer Research, Kanzawa Medical Research Foundation, and The Ichiro Kanehara Foundation. Funding Information: We sincerely appreciate the generous donation of PSMB9/β1i-deficient breeding mice and technical comments by Luc Van Kaer, at Massachusetts Institute of Technology. We thank Isamu Ishiwata for his generous gift of the human Ut-LMS cell lines. We appreciate the technical assistance of the research staff at Harvard Medical School. We are grateful to clinical staffs at Hyogo Cancer Center for Adults for clinical materials and helpful discussion. This clinical research was performed with the support of the following research funding: Japan Society for the Promotion of Science for TH (grant No. 19K09840), START-program Japan Science and Technology Agency (JST) for TH (grant No. STSC20001), and National Hospital Organization Multicenter clinical study for TH (grant No. 2019-Cancer in general-02). This work was supported by grants from the Ministry of Education, Culture, Science and Technology (No. 15K10709), START-project of Japan Science and Technology Agency, the Foundation for the Promotion of Cancer Research, Kanzawa Medical Research Foundation, and The Ichiro Kanehara Foundation.

PY - 2021/10/15

Y1 - 2021/10/15

UR - http://www.scopus.com/inward/record.url?scp=85118513484&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85118513484&partnerID=8YFLogxK

U2 - 10.31083/j.ejgo4205125

DO - 10.31083/j.ejgo4205125

M3 - Review article

AN - SCOPUS:85118513484

VL - 42

SP - 824

EP - 828

JO - European Journal of Gynaecological Oncology

JF - European Journal of Gynaecological Oncology

SN - 0392-2936

IS - 5

ER -

Potential biomarkers associated with malignancy in uterine mesenchymal tumors

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this